ANALYSIS. The global leader in cataract surgery will not be able to offer an accommodative intraocular lens after the ...

Alcon raised full-year core EPS growth guidance to 12% to 15% in constant currency, exceeding expectations, even as a $402 million pre-tax impairment from the scrapped PowerVision lens programs ...

By Simon Ferdinand Eibach Aug 11 (Reuters) - Swiss-American eye care company Alcon hiked its 2026 profitability target on Monday, helped by U.S. tariff refunds, which sent its shares around 4% higher ...

By Simon Ferdinand Eibach Aug 11 (Reuters) - Swiss-American eye care company Alcon on Monday hiked its profit guidance and lowered its estimate for the full-year tariff impact to $40 million to $90 ...

Alcon Inc. ( ALC) Q2 2026 Earnings Call August 11, 2026 8:00 AM EDT Greetings. Welcome to Alcon's Second Quarter 2026 Earnings Call. [Operator Instructions] Please note, this conference is being ...

Alcon (ALC) stock surged 3% after raising EPS guidance to 12%-15% and cutting tariff impact forecast to $40M-$90M, down from $100M-$150M previously.

The ophthalmic products company Alcon continued to grow in the second quarter of 2026. It is now raising its full-year ...

Former Novartis subsidiary Alcon, after targeting the pharmaceutical eye drop scene with a trio of recent drug purchases, is adding another pair of arrows to its ophthalmic quiver. And this time, the ...

Q2 2026 earnings call recap: guidance withdrawn, Alcon revenue outlook, weaker sales and utilization, and sales-team expansion ...

Geneva, Switzerland-based Alcon and Orlando, FL-based Lensar have entered a merger agreement through which Alcon intends to acquire Lensar. The acquisition includes the Ally robotic cataract laser ...